Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 140

1.

Loss of BAP1 Expression in Basal Cell Carcinomas in Patients With Germline BAP1 Mutations.

Mochel MC, Piris A, Nose V, Hoang MP.

Am J Clin Pathol. 2015 Jun;143(6):901-4. doi: 10.1309/AJCPG8LFJC0DHDQT.

PMID:
25972334
2.

Germline BAP1 mutations predispose also to multiple basal cell carcinomas.

de la Fouchardière A, Cabaret O, Savin L, Combemale P, Schvartz H, Penet C, Bonadona V, Soufir N, Bressac-de Paillerets B.

Clin Genet. 2015 Sep;88(3):273-7. doi: 10.1111/cge.12472. Epub 2014 Sep 8.

PMID:
25080371
3.

Tumours associated with BAP1 mutations.

Murali R, Wiesner T, Scolyer RA.

Pathology. 2013 Feb;45(2):116-26. doi: 10.1097/PAT.0b013e32835d0efb. Review.

PMID:
23277170
4.

A recurrent germline BAP1 mutation and extension of the BAP1 tumor predisposition spectrum to include basal cell carcinoma.

Wadt KA, Aoude LG, Johansson P, Solinas A, Pritchard A, Crainic O, Andersen MT, Kiilgaard JF, Heegaard S, Sunde L, Federspiel B, Madore J, Thompson JF, McCarthy SW, Goodwin A, Tsao H, Jönsson G, Busam K, Gupta R, Trent JM, Gerdes AM, Brown KM, Scolyer RA, Hayward NK.

Clin Genet. 2015 Sep;88(3):267-72. doi: 10.1111/cge.12501. Epub 2014 Nov 6.

PMID:
25225168
5.

BAP1 and BRAFV600E expression in benign and malignant melanocytic proliferations.

Piris A, Mihm MC Jr, Hoang MP.

Hum Pathol. 2015 Feb;46(2):239-45. doi: 10.1016/j.humpath.2014.10.015. Epub 2014 Nov 4.

PMID:
25479927
6.

Basal cell carcinomas developing independently from BAP1-tumor predisposition syndrome in a patient with bilateral uveal melanoma: Diagnostic challenges to identify patients with BAP1-TPDS.

Melzer C, Sharma A, Peters S, Aretz S, Biswas A, Holz FG, Loeffler KU, Herwig-Carl MC.

Genes Chromosomes Cancer. 2019 Jun;58(6):357-364. doi: 10.1002/gcc.22724. Epub 2019 Jan 23.

PMID:
30578689
7.

Melanoma With Loss of BAP1 Expression in Patients With No Family History of BAP1-Associated Cancer Susceptibility Syndrome: A Case Series.

Aung PP, Nagarajan P, Tetzlaff MT, Curry JL, Tang G, Abdullaev Z, Pack SD, Ivan D, Prieto VG, Torres-Cabala CA.

Am J Dermatopathol. 2019 Mar;41(3):167-179. doi: 10.1097/DAD.0000000000001217.

PMID:
30801340
8.

A population-based analysis of germline BAP1 mutations in melanoma.

O'Shea SJ, Robles-Espinoza CD, McLellan L, Harrigan J, Jacq X, Hewinson J, Iyer V, Merchant W, Elliott F, Harland M, Bishop DT, Newton-Bishop JA, Adams DJ.

Hum Mol Genet. 2017 Feb 15;26(4):717-728. doi: 10.1093/hmg/ddw403.

9.

Histomorphologic spectrum of germline-related and sporadic BAP1-inactivated melanocytic tumors.

Garfield EM, Walton KE, Quan VL, VandenBoom T, Zhang B, Kong BY, Isales MC, Panah E, Kim G, Gerami P.

J Am Acad Dermatol. 2018 Sep;79(3):525-534. doi: 10.1016/j.jaad.2018.05.005. Epub 2018 May 10.

PMID:
29753057
10.

Melanomas Associated With Blue Nevi or Mimicking Cellular Blue Nevi: Clinical, Pathologic, and Molecular Study of 11 Cases Displaying a High Frequency of GNA11 Mutations, BAP1 Expression Loss, and a Predilection for the Scalp.

Costa S, Byrne M, Pissaloux D, Haddad V, Paindavoine S, Thomas L, Aubin F, Lesimple T, Grange F, Bonniaud B, Mortier L, Mateus C, Dreno B, Balme B, Vergier B, de la Fouchardiere A.

Am J Surg Pathol. 2016 Mar;40(3):368-77. doi: 10.1097/PAS.0000000000000568.

PMID:
26645730
11.

Multiple Cutaneous Melanomas and Clinically Atypical Moles in a Patient With a Novel Germline BAP1 Mutation.

Gerami P, Yélamos O, Lee CY, Obregon R, Yazdan P, Sholl LM, Guitart GE, Njauw CN, Tsao H.

JAMA Dermatol. 2015 Nov;151(11):1235-9. doi: 10.1001/jamadermatol.2015.1701.

12.

A novel BAP1 mutation is associated with melanocytic neoplasms and thyroid cancer.

McDonnell KJ, Gallanis GT, Heller KA, Melas M, Idos GE, Culver JO, Martin SE, Peng DH, Gruber SB.

Cancer Genet. 2016 Mar;209(3):75-81. doi: 10.1016/j.cancergen.2015.12.007. Epub 2015 Dec 22.

13.

CDKN2A and BAP1 germline mutations predispose to melanoma and mesothelioma.

Betti M, Aspesi A, Biasi A, Casalone E, Ferrante D, Ogliara P, Gironi LC, Giorgione R, Farinelli P, Grosso F, Libener R, Rosato S, Turchetti D, Maffè A, Casadio C, Ascoli V, Dianzani C, Colombo E, Piccolini E, Pavesi M, Miccoli S, Mirabelli D, Bracco C, Righi L, Boldorini R, Papotti M, Matullo G, Magnani C, Pasini B, Dianzani I.

Cancer Lett. 2016 Aug 10;378(2):120-30. doi: 10.1016/j.canlet.2016.05.011. Epub 2016 May 12.

14.

Histomorphologic spectrum of BAP1 negative melanocytic neoplasms in a family with BAP1-associated cancer susceptibility syndrome.

Marušić Z, Buljan M, Busam KJ.

J Cutan Pathol. 2015 Jun;42(6):406-12. doi: 10.1111/cup.12493. Epub 2015 May 12.

PMID:
25902915
15.

Germline BAP1 inactivation is preferentially associated with metastatic ocular melanoma and cutaneous-ocular melanoma families.

Njauw CN, Kim I, Piris A, Gabree M, Taylor M, Lane AM, DeAngelis MM, Gragoudas E, Duncan LM, Tsao H.

PLoS One. 2012;7(4):e35295. doi: 10.1371/journal.pone.0035295. Epub 2012 Apr 24.

16.

Germline mutations in BAP1 predispose to melanocytic tumors.

Wiesner T, Obenauf AC, Murali R, Fried I, Griewank KG, Ulz P, Windpassinger C, Wackernagel W, Loy S, Wolf I, Viale A, Lash AE, Pirun M, Socci ND, Rütten A, Palmedo G, Abramson D, Offit K, Ott A, Becker JC, Cerroni L, Kutzner H, Bastian BC, Speicher MR.

Nat Genet. 2011 Aug 28;43(10):1018-21. doi: 10.1038/ng.910.

17.

Comparison of Germline versus Somatic BAP1 Mutations for Risk of Metastasis in Uveal Melanoma.

Ewens KG, Lalonde E, Richards-Yutz J, Shields CL, Ganguly A.

BMC Cancer. 2018 Nov 26;18(1):1172. doi: 10.1186/s12885-018-5079-x.

18.

A distinct subset of atypical Spitz tumors is characterized by BRAF mutation and loss of BAP1 expression.

Wiesner T, Murali R, Fried I, Cerroni L, Busam K, Kutzner H, Bastian BC.

Am J Surg Pathol. 2012 Jun;36(6):818-30. doi: 10.1097/PAS.0b013e3182498be5.

19.

Germline BAP1-positive patients: the dilemmas of cancer surveillance and a proposed interdisciplinary consensus monitoring strategy.

Star P, Goodwin A, Kapoor R, Conway RM, Long GV, Scolyer RA, Guitera P.

Eur J Cancer. 2018 Mar;92:48-53. doi: 10.1016/j.ejca.2017.12.022. Epub 2018 Feb 3.

PMID:
29413689
20.

Genotypic and Phenotypic Features of BAP1 Cancer Syndrome: A Report of 8 New Families and Review of Cases in the Literature.

Haugh AM, Njauw CN, Bubley JA, Verzì AE, Zhang B, Kudalkar E, VandenBoom T, Walton K, Swick BL, Kumar R, Rana HQ, Cochrane S, McCormick SR, Shea CR, Tsao H, Gerami P.

JAMA Dermatol. 2017 Oct 1;153(10):999-1006. doi: 10.1001/jamadermatol.2017.2330. Review.

Supplemental Content

Support Center